top of page

Search our Site. Find Results Fast.

Search this site

257 results found with an empty search

Other Pages (65)

  • Global SDS Action Week & Awareness Day | SDS Alliance

    The Global SDS Action Week and Awareness campaign started in 2021 for the global SDS community to join forces, work toward better treatments, and raise awareness about SDS. Motivated families and organizations put on their own events or join together. Our creativity and passion has no limits! Shwachman-Diamond Syndrome - #CureSDS Global SDS Action Week and Awareness Day What's Global SDS Awareness Day & Action Week? Global SDS Action Week and Awareness Day is about coming together and raising awareness as a united global patient community. In 2020, SDS Alliance reached out to all the international SDS patient organizations to discuss the idea of creating an annual Global SDS Awareness event, proposing a time in spring or fall to avoid the busy winter holiday and summer vacation seasons. Our colleagues at SDS UK proposed late April as the time to coincide with Dr. Shwachman's birthday. All organizations that responded - including SDS UK, SDS Netherlands, and SDS Foundation (US) - supported this concept and timing, and so Global SDS Awareness Week was born. Over the years, the event has not reached its full potential, so we set out to reconsider the date. We polled the international patient community for a new date/frame preference. You voted and we listened! Based on your feedback, the new date(s) are: Global SDS ACTION Week is November 1-7 culminating in SDS Awareness Day on November 7 Take Action to Make an Impact! This year, we put the whole week in one place. Our new interactive guide gives you one action a day, with a short note on why it matters and a link to get started. Check off what you do. Skip what doesn't fit your life right now. Every action is optional, and you can do them in any order, anywhere in the world. Click to open your checklist! Share a vocal video! We partnered with Vocal Video to bring you a super easy way to share your voice by answering a few simple questions. Here is Eszter's example. Click here or below to share your voice, today! This tool walks you through a few questions and creates a video of about 3 minutes or more, depending on how much you want to share. Coming soon, we may offer a shorter option. Let us know what you think. Click to create YOUR Video We will use your videos to raise awareness about SDS and to inform our programs to best support your needs! Get your T-shirts to support the cause! Click on the design to order. Multiple colors and styles are available, including t-shirts, hoodies, and tank tops. International shipping is available. If you would like to have them printed locally in your country or community, email us at connect@sdsalliance.org and we will be happy to share the design file! Why November? Dr. Shwachman was a prominent gastroenterologist in Boston in the 1960s and developed deep expertise in caring for Cystic Fibrosis (CF) patients and "atypical" CF patients. This was before SDS was recognized as a distinct disorder, and many patients were categorized as "atypical CF." Drs. Shwachman and Diamond , as well as Dr. Bodian , were instrumental in defining Shwachman-Diamond Syndrome. A landmark publication in the journal Pediatrics in 1964, entitled "The Syndrome of Pancreatic Insufficiency and Bone Marrow Dysfunction " was published by Drs. Shwachman and Diamond in November 1964. It is due to this publication that the disease received its name, "Shwachman-Diamond Syndrome". About 40 years later, Dr. Johanna Rommens and her team at SickKids in Toronto, Canada, identified the main gene responsible for SDS. The gene (and corresponding protein) was named SBDS for Shwachman-Bodian-Diamond Syndrome to acknowledge Dr. Bodian's contribution to the field. Coincidentally, the SBDS gene happens to be located at 7q11, meaning chromosome 7, section 11, giving a nod to the date of 11.7 or November 7. Why participate? It is our hope that more and more organizations and families will participate over time so that this campaign can grow and reach more families, medical providers, and researchers. We have reached out to all international SDS patient groups to invite them. Each action connects to research, better care, or a stronger community. More families in SDS-GPS and the PACER course makes a stronger case to researchers and funders. Sharing the ICD-10 code and genetic testing information helps more people get diagnosed sooner, so treatment can begin sooner. The SDS community can grow to support more targeted research, accelerating the pace toward therapies and cures. Additional ideas to take action Both patient advocacy groups AND individual patients and families are invited to host events in their communities, be it a bake sale, gala, golf tournament, walk, or any event that works for you and your community. Let us know if we can help in any way! We would love to post your events below and help spread the word. If you have questions about any particular event or campaign, please reach out to the hosting organization or family directly. Donations to any of the participating SDS organizations are always welcome and appreciated. Visit their respective websites for details. If you are an SDS patient or family looking for peer-to-peer support or local support organizations, please check out the list on the SDS Alliance website, here . General information about SDS for patients and families can be found here . SDS Story Series Huge thanks to all the SDS families from around the world for sharing their stories! The stories are available on our blog (Patient Stories) and Social Media Channels. One meaningful action you can take this SDS Action Week and Awareness Day is to share your story. We are looking for stories from around the world, because SDS affects families in a wide variety of ways. Sharing them helps more patients get diagnosed sooner and find community support and better treatments. It also shows the world that the SDS community is strong and worthy of investment toward new therapies and cures. Share your story for our blog by emailing us or using the upload form or Share you story of our Essential Guide Visit our Patient Stories page, contact the SDS Alliance on Facebook or email us at connect@SDSAlliance.org .

  • SDS-GPS: Make your voice count | Shwachman-Diamond Syndrome Alliance

    The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) is an opportunity for patients and their families - from anywhere in the world - to share their experience living with SDS via a safe, secure, and convenient online platform, with the goal of * expanding the understanding of SDS * improving the lives of people with SDS, and * accelerating the development of new therapies and cures for SDS. Join SDS-GPS now Destination Cure. Driven by You. Join by Creating an Account Existing Account Login SDS-GPS and More Publications SDS-GPS is an Opportunity for You to Accelerate Therapy Development and a Cure for SDS The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) is an opportunity for patients and their families - from anywhere in the world - to share their experience living with SDS via a safe, secure, and convenient online platform, to expand the understanding of SDS improve the lives of people with SDS, and accelerate the development of new therapies and cures for SDS. By joining, participants will receive early access to relevant information about new clinical trials and other research opportunities (such as clinical registries) based on their profile, accelerating research and increasing clinical trial design and recruitment success. Joining is Quick & Easy All you need: 30-60 minutes of your time (you can take breaks) The patient's genetics report (if available). Learn more . A computer or mobile device with internet Optional: Schedule a call with our team if you would like help with getting started. Click here for our calendar booking link and select how long you would like to meet with us on Zoom. Join Us to Make an Impact Be the first to know about clinical trials and research opportunities relevant to you, based on your profile, mutation, symptoms, and demographics Drive research by expanding the knowledge about SDS and informing clinical trials' needs and designs Become an integral part of a global community that cares Your experience - whether it falls in the mild or severe end of the spectrum - matters. Your voice counts. We strive to make this opportunity available to all patients/families by making it accessible from anywhere, anytime. We are excited to share that the SDS-GPS platform and surveys are now available in 5 languages: English, Spanish, French, Italian, and German. We are looking to add more languages as funding allows. English Espanol (Spanish) Francais (French) Italiano (Italian) Deutsch (German) What aspects of my story can I share through SDS-GPS? Surveys on the SDS-GPS Program Platform are designed to be quick and easy, without the need to have to look up any details from medical records. You can save your progress and come back anytime. Survey topics include: Socio-demographics Medical history and diagnostics Treatment and disease progression Management of and access to care Quality of life. Learn more . Additional aspects of life with SDS - your human story - are extremely valuable as well, and we are looking to help you share those through other SDS Alliance programs. For example, check out our resource page on patient stories. How can my story help drive therapies and cures? Your story helps paint a more complete picture of what SDS is and how it impacts the people living with it. Your participation helps build a strong, engaged community, which is critical to drive progress. Without patients and their families, research cannot advance. We (the SDS-GPS team at the SDS Alliance) use your de-identified aggregate survey responses and other data you share to develop a deeper understanding of the unmet needs of the community. We use the insights to Prioritize research, educational resources, and community programming Promote data and knowledge sharing via collaborations, publications, conference presentations, and other communication channels Provide you with information about relevant research opportunities (such as the SDS Registry and other natural history studies), clinical trials, educational resources, and community support connections. How does SDS-GPS work? Sign up for a free SDS-GPS account (hosted by Matrix) in 4 easy steps and tell us a little bit about yourself or your loved one. Enrolling and participating takes little time, and you can come back later to update your information. Answer surveys from the comfort of your home at any time that works for you. Upload your genetics report if available, or at a later. Learn more . Privacy and security are protected to the highest standard. Learn more . Move research forward without any clinic visits or virtual appointments. With your consent, we publish and share de-identified data (your survey responses) with approved researchers to support research to benefit the SDS community. The information you provide through easy surveys is structured and coded behind the scenes, to be usable for high-quality, impactful research. Keep track of your or your loved one’s medical appointments, medications, and symptoms via your SDS-GPS account, and have all the information at your fingertips whenever and wherever you need it. You can share any information you like with your care team. You retain full control over access. Patients, Parents, Caregivers: Join in 4 simple steps! Create an Account Download Quick Start Guide Step 1: Create an account Request access to create an SDS-GPS account on the Matrix platform. You will be asked to confirm your email address and create a secure password. Frequently Asked Questions: How is my information used and protected? Who will be able to view my information? In addition to the SDS-GPS team as part of the SDS Alliance, the following are groups with whom your Program team may share your de-identified data and samples to support research and therapy development. All these entities will have oversight committees (such as an IRB) that will supervise the ethical use of the data and samples and protect the participants. • Health authorities throughout the world (e.g., U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other governing bodies that review clinical trials). • Institutional Review Boards (IRB) that oversee and review the ethics of the research. • The program sponsor (SDS Alliance) and those working for or with the sponsor, which may include affiliates of the sponsor located in your country or other countries. • Other groups: Examples of which include academic, government, or industry researchers; public-private partnerships; and/or external research collaborations. • Programs and platforms to facilitate the sharing of de-identified data and combining multiple datasets, such as the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), European Rare Disease Registry Infrastructure (ERDRI), or Terra by the Broad Institute. Is my information secure? The SDS-GPS Program data will be stored on secure servers located in the United States of America (U.S.). Data entry may be performed anywhere in the world via web interface. For persons living outside the U.S. who choose to share information about themselves, the same protections for privacy and confidentiality are offered as in the U.S. Privacy laws in other countries, such as General Data Protection Regulation (GDPR), may have different protections than those provided in the U.S. Participants’ data may be transferred to the U.S. (e.g. to servers physically located in the U.S.). • Participants’ privacy and confidentiality will be safeguarded by using modern database management techniques and informed consent. As part of consent, participants will have the ability to state whether future re-contact is acceptable. SDS-GPS Program staff may contact participants to clarify data entry. • Confidentiality will be protected by limiting access to data and keeping Protected Health Information (PHI) password protected on a secure server. "Protected Health Information" or PHI is a term used for health-related information that can specifically identify a patient, for example, their name, date-of-birth, and place of birth, etc. Privacy and confidentiality risks will be minimized by the following means: • Access to PHI in the database will be limited to as few SDS-GPS Program team members as possible. • All team members with access to PHI will have to go through CITI or similar training on how to protect PHI. • Participants will be assigned a unique patient identification number or will be asked to provide a research ID they may have received from a third party (such as the Clinical Research ID (CRID)). Any data that is shared will be labeled with this unique identifier instead of participants’ PHI, such as their name, picture or any other identifying information. • PHI and other data are kept safe using the highest encryption standard available and protected via password-protected and encryption security measures. Do I have to participate in this program? If I choose to participate, can I change my mind and withdraw later? Participation in the SDS-GPS Program is voluntary. Participants are free to withdraw at any time, for any reason. To withdraw, they will need to contact the SDS-GPS Program team by email at GPS@SDSAlliance.org. Refusing to participate will involve no penalty or loss of benefits to which one is otherwise entitled. Participants have the right to ask that we delete their personal information. If we still have their personal identifiers (PHI), we will delete them to the extent possible and unlink their data from any information that could identify them. De-identified information no longer connected to PHI cannot be identified and won’t be deleted. De-identified information that has already been shared with researchers or groups cannot be retrieved or removed. Who will information from the Program be shared with, and how? Identified Data: Identified data, including PHI, is protected and won’t be shared outside the SDS-GPS Program. "Protected Health Information" or PHI is a term used for health-related information that can specifically identify a patient, for example, their name, date-of-birth, and place of birth, etc. De-identified data: For de-identified data (i.e. data that is no longer linked to a specific person), there are several types of data access and dissemination options. • Aggregate Data. Such information may include the number of participants, the prevalence of individual common diagnoses, demographic information, and percent willingness to be re-contacted for future research. • De-identified, Patient-level Data. De-identified data is available for researchers to use in statistical analysis for pre-clinical explorations, publications, presentations, grant preparations, and more. Researchers can apply for access via an application form. All applications will be reviewed by the Data Access Committee. • Support in identifying and recruiting patients for clinical trials and other research studies. Requests will be reviewed by the Data Access Committee. IRB approved recruitment material will be distributed by the SDS-GPS Program team. No patient list will be shared with third parties. • Investigators wanting to use the SDS-GPS Program data need to apply to the Data Access Committee. The Committee is composed of the Program Principal Investigator, patient representative, and members with scientific, medical, legal and/or ethical expertise. It ensures that the request for data use aligns with the purposes of the Program and its policy. The application requires providing the following information through an online form or by email to the Program team at GPS@SDSAlliance.org: • Principal Investigator (Name, contact information, and CV) • Aims and hypotheses of the proposed research • Where and how the research will be performed • How the research will be funded • How the results will be published and/or shared, and • What type of data access is requested A data transfer agreement will be distributed ahead of the data, specifying the agreed-upon scope of research to be performed and specifying that no attempt may be made to identify the SDS-GPS Program participants. Can my doctor or medical professionals view my information? Participants have the option to access and share their own data in the SDS-GPS Program Platform. Physician access to the platform may be available in the future, upon written permission of the participant. What is the SDS-GPS Program? What is the purpose of the SDS-GPS Program? The SDS-GPS Program stands for Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program. It was created in 2023 by the Shwachman-Diamond Syndrome Alliance, Inc. - a patient-centric research-focused nonprofit research organization based in the US, serving the global SDS community - in order to enable and accelerate the development of therapies and cures for Shwachman-Diamond Syndrome (SDS) and related disorders and to optimize patient care. How will SDS-GPS contribute to research? The purpose of the SDS-GPS Program is to enable and accelerate therapy development and disease understanding by • Collecting standardized data through validated surveys, medical records, and other means, in a consistent way and from as many individuals as possible. This is essential for (ultra-)rare diseases like SDS to enable progress. The Program is aimed at enabling the development of patient-reported outcome measures (PROs) and real-world evidence (RWE) through the collection and analysis of real-world data (RWD). • Incorporating the patient voice into all aspects of the research and therapy development continuum. One important tool to capture the patients’ voice and to support the development of patient-centric priorities is the use of surveys to assess the needs of the SDS and related disorder communities. • Making data available to any researcher who wants to better understand SDS, related disorders, community needs, and work toward improved care and novel therapies. We want as many scientists as possible around the world working on SDS and related disorders toward therapies and cures. • Developing a database of people who may be interested in participating in future studies, including clinical trials, with all the necessary information about them already in place. We encourage all patients to consider participating in any registry or study available to them. • Driving collaborations between all stakeholders, including patients, registries, researchers, clinicians, and regulators. We are leading the way by building collaboration opportunities and data sharing frameworks into all our programs. Who can join SDS-GPS? The Program is open to patients of all ages who have a confirmed diagnosis of the below, using established diagnostic guidelines, plus their parents/caregivers. • Patients with a confirmed Shwachman-Diamond Syndrome (SDS) diagnosis, including a genetic or clinical diagnosis. The initial focus will be on patients with a genetic diagnosis of SDS based on biallelic mutations in SBDS or EFL1. • Patients with a confirmed diagnosis of an SDS-like syndrome (e.g. due to mutations in DNAJC21, SRP54, or other genes that may be associated with an SDS-like syndrome in the future). • Patients with other heritable hematological malignancy disorders (such as RUNX1-FPD, Fanconi Anemia) and/or congenital neutropenias (such as ELANE neutropenia) are also eligible for inclusion. • Caregivers, parents, and close relatives of all patients above, including of patients alive or deceased. What are the benefits of joining SDS-GPS? There may be no direct benefit to the participants associated with articipation in the SDS-GPS Program. However, by giving approval for your de-identified data and samples to be shared for research purposes, your valuable contributions have the best chance to be used as effectively as possible for research not only today but also in the future as new research questions and technologies emerge. Furthermore, by providing your contact information and agreeing to be re-contacted by the SDS-GPS program, you will be able to receive the most relevant information about your (or the participant’s) disorder, support services and connections, educational resources, information about relevant clinical trials, and access tools to store and manage their own health records and information. Are there any risks to participating in the Program? Could it cause me any harm? Participation in the SDS-GPS Program presents minimal risks to its participants. The risks are related to privacy. There are no risks of physical harm associated with participation in the SDS-GPS Program. Participation in the SDS-GPS Program does involve the potential risks of a breach of confidentiality of medical information and the associated privacy of the participants. Is the SDS-GPS Program a clinical trial, a registry, or both? According to the NIH, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure and that serves predetermined scientific, clinical, or policy purpose(s). Studies derived from well-designed and well-performed patient registries can provide a real-world view of clinical practice, patient outcomes, safety, and clinical, comparative, and cost-effectiveness, and can serve a number of evidence-development and decision-making purposes. In this sense, the SDS-GPS Program could be considered a "registry," but it is so much more than that. It gives patients a voice and builds community and collaborations between stakeholder groups (patient, caregiver, researcher, and clinician communities). The main difference between registry studies and clinical studies or clinical trials is that registry studies are observational (passively observing the natural history or normal progression of the disease, untreated or using current standards of care), whereas clinical studies are investigational (investigators are instructed to treat the condition in a certain way, and then outcomes are measured). The SDS-GPS Program is applying to be registered on ClinicalTrails.gov. What is a registry? And is the SDS-GPS Program a registry? The SDS-GPS Program could be considered a patient-powered registry, but it is much more than that. In addition to collecting patient data, it is focused on sharing the data, building collaboration, and empowering patients by providing them access to their data and modern tools to manage their data. “Patient registries have been defined as “an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose(s).” In brief, a patient registry is a collection—for one or more purposes—of standardized information about a group of patients who share a condition or experience.” In what languages can I participate? The SDS-GPS Program platform (hosted by Matrix) is available in several languages, including English, Spanish, German, Italian, and French. Most surveys administered on the platform are also available in several languages. We are striving to add more languages based on the needs of the community and capacity. Why is patient-reported data so important? Patient-reported data is crucial for drug development and FDA (U.S. Food and Drug Administration) approval for several reasons. Including patient perspectives and experiences in the evaluation process enhances the overall understanding of a drug's effectiveness and safety. • Patient-Centric Focus: Incorporating patient-reported outcomes (PROs) ensures that drug development is centered around patients' experiences and the impact of the condition on their daily lives. This patient-centric focus aligns with the goal of developing treatments that genuinely address patients' needs and improve their quality of life. • Measuring Treatment Benefits: Patient-reported data provides direct insight into the benefits of a treatment from the patient's perspective. This information is particularly valuable in assessing the drug's impact on symptoms, functioning, and overall well-being, which may not be fully captured by traditional clinical measures alone. • Endpoint Selection: Patient-reported outcomes can help inform the selection of meaningful and relevant endpoints for clinical trials. By including endpoints that matter to patients, researchers can design studies that better reflect the real-world impact of a drug, making the results more applicable to patients' experiences. • Clinical Trial Design and Recruitment: Patient-reported data is essential in the design of clinical trials, helping researchers determine the appropriate study population, design patient-friendly protocols, and enhance recruitment strategies. This contributes to the overall success and efficiency of clinical trials. • Regulatory Requirements: Regulatory agencies, such as the FDA, increasingly recognize the importance of patient-reported data in evaluating drug safety and efficacy. In many cases, the FDA requires the inclusion of PROs in clinical trial protocols, and positive patient-reported outcomes can support a drug's approval by demonstrating its meaningful impact on patients' lives. • Labeling and Communication: Patient-reported data can influence the content of drug labels, ensuring that important information about the drug's benefits and risks is communicated clearly to healthcare providers and patients. This transparency aids in informed decision-making and appropriate use of the medication. • Post-Marketing Surveillance: Patient-reported data continues to be valuable after a drug is on the market. Monitoring patient experiences and outcomes post-approval helps identify any previously unrecognized side effects, assess long-term benefits, and guide further recommendations for use. • Health Economics and Market Access: Patient-reported outcomes contribute to health economic assessments and market access strategies. Demonstrating the positive impact of a drug on patients' lives can influence reimbursement decisions and market access, making the drug more widely available to those who need it. • In summary, patient-reported data is integral to the drug development process, providing a comprehensive understanding of a drug's benefits and risks. Its inclusion enhances the credibility of clinical trials, regulatory submissions, and post-marketing evaluations, ultimately contributing to improved healthcare decision-making and better outcomes for patients. Who is sponsoring (paying for) the SDS-GPS Program? Are there any third parties involved? The initial design and implementation of the Program, as well as annual maintenance, will be funded by the Shwachman-Diamond Syndrome Alliance (“SDS Alliance”) - the Sponsor. In order to maximize the impact of the participant’s data and efforts, we invite and encourage researchers from other organizations and companies to apply for and access certain sets of data. The SDS Alliance may get paid by some of these partners and will use the proceeds to sustain and grow the SDS-GPS Program and other programs to benefit the SDS community. How can I support the SDS-GPS Program? Your participation (enrolling in SDS-GPS and filling out surveys) is the most important way to support this program. Additionally, financial support for the SDS Alliance is always impactful, as all its programs are focused on accelerating therapy development and cures, and improving patient care. Turning hope into action, together. How Can I Participate in the Program? What will I need to do in order to participate? Participants will need to follow the following steps to participate in the Program: • Setting up an account on the SDS-GPS Program platform, which can be done by a caregiver or patient. • Adding participants (which can be patients, parents, caregivers, or close relatives) • Providing informed consent (IRB approved) for each participant (online on the Program platform) including options to agree to be re-contacted. • Adding contact and demographic information about each participant(s) • Uploading the genetics report of the participant(s), if available. • Answering surveys (about the participant’s physical and mental health, quality of life measures, the burden of disease, community needs assessment, and other aspects of SDS and related disorders) that are available in the participant’s account on the Program platform. Most of the surveys need to be answered on an annual basis or more, in order to track changes to their experience over time. The Program platform or team may send reminders to update surveys and other information. Participants may also have the opportunity to contribute additional types of data, such as • connecting their electronic health records (EHR), answering interview questions, allowing their healthcare provider to add health information on their behalf, uploading additional test results and lab measurements, connecting metrics from devices, and new technologies yet to be developed. • data associated with samples for biobanking and research. Sample collection and banking are governed under separate protocols and IRB. What is Informed Consent? Informed Consent is a process in which patients and research participants are given important information, including possible risks and benefits, about a medical procedure or treatment, genetic testing, a clinical trial, or studies, registries, and data collection programs. This is to help them decide if they want to participate. Patients are also given any new information that might affect their decision to continue. Who should provide informed consent on behalf of the participant? Any individual considered a legal adult (also known as someone over the age of majority) who is diagnosed with Shwachman-Diamond Syndrome (SDS) or related disorders who is able to understand this consent form and wants to participate in this program should consent on their own behalf. • A parent or guardian may enroll a child who is under the age of majority (in many places, under the age 18 years). Please see ascent instructions in the consent form. The SDS-GPS program team will contact each participant who was enrolled as a child, upon reaching the age of majority, explain the purpose of the program, and seek their consent to continue their participation. In other words, individuals for whom their parents provided consent will be asked to provide their own consent when they reach the age of majority. • A Legally Authorized Representative (LAR) may enroll an adult over the age of majority who is unable to consent. • Family members or caregivers of a patient who has passed away can also participate and provide information about the deceased patient. No formal Informed Consent is necessary, but the information presented here may still be helpful for understanding the Program. What is a genetic report? Why are you asking for it? Genetic confirmation of your diagnosis is very important for both optimizing your own healthcare and also for research. Without it, researchers cannot determine whether a specific gene or mutation is responsible for the symptoms you experience. Please upload it to the SDS-GPS Program platform when prompted. As with all personal information, it will be protected with utmost care. If you have never had genetic testing or are having a hard time accessing testing, please reach out to us at genetics@SDSAlliance.org. We may be able to help you access free genetic testing options or point you to relevant resources or experts. A genetics report, also known as a genetic test report or genetic analysis report, is a document that provides information about an individual's genetic makeup based on the results of genetic testing. Genetic testing involves the analysis of an individual's DNA to identify variations or mutations in specific genes associated with certain traits, conditions, or susceptibilities. Genetic reports typically include: • Personal Information: Name, date of birth, and other relevant demographic details of the individual undergoing genetic testing. • Test Information: Details about the specific genetic test or tests conducted, including the methodologies used and the genes or regions of the genome analyzed. • Genetic Variants: Identification of specific genetic variants found during the testing process. These variants may include single nucleotide polymorphisms (SNPs), insertions, deletions, or other genetic alterations. • Interpretation of Results: Explanation of the significance of the identified genetic variants. This section may classify variants as normal, pathogenic (associated with a disease or condition), or of uncertain significance. • Genetic Conditions or Traits: Information about any genetic conditions, predispositions, or traits associated with the identified variants. This may include details about the risk of developing certain diseases, carrier status for genetic disorders, or information about drug response and metabolism. • Risk Assessment: If applicable, an assessment of the individual's risk for developing specific diseases or conditions based on the identified genetic variants. • Clinical Implications: Recommendations or implications for medical management, surveillance, or preventive measures based on the genetic findings. • Inheritance Patterns: Information on how the identified genetic variants may be inherited and whether they follow an autosomal dominant, autosomal recessive, or other inheritance pattern. • Limitations of the Test: Discussion of the limitations of the genetic test, including potential false-positive or false-negative results, and the scope of conditions covered by the test. • Genetic Counseling Recommendations: Guidance on the importance of genetic counseling and recommendations for further discussions with a genetics professional to fully understand the implications of the genetic test results. It's crucial to note that genetic testing should be carried out under the supervision of healthcare professionals, and the interpretation of results often requires expertise in genetics. Genetic reports are valuable tools that can inform medical decision-making, risk assessment, and personalized healthcare planning based on an individual's genetic profile. What if I don’t have a genetics report? If you have received genetic testing for SDS and/or related disorders but don’t have access to a copy, please check with your healthcare provider or testing company on how to access it. We may be able to help with the process of obtaining a copy on your behalf with specific paperwork. Please contact us at genetics@SDSAlliance.org for assistance. If you don’t have access to genetic testing, we may be able to assist! We can connect you to experienced doctors and no-cost testing options almost anywhere in the world. We can also provide information on testing strategies and interpretation to your physician or connect them with local experts. Please contact us at GPS@SDSAlliance.org for assistance. Can I learn more about my genetics when I upload my report? Before you upload your genetics report, you will have the option to indicate whether you would like us to inform you if new information becomes available about the genes and variants described in your report. As we learn more about genetic changes, our understanding of their relationship to health might change. For example, the classification of Variants of Unknown Significance (VUS) may change over time, or new genes may be discovered that could explain symptoms or disorders. Some updates may impact your medical care, while others may not. Such updates are rare, so most participants will not receive updates. It is not possible for us to identify all updates related to participants’ genetic test results. Answering “Yes” means that you may be contacted by our team if we learn about potential updates to your/the participant’s genetic test results. Our email would direct you back to your doctor or a healthcare provider in your area to discuss possible updates in more detail, as our team is not able to provide medical care. Please contact us at genetics@SDSAlliance.org for assistance. Will I be able to view or change my responses after completing a survey? Yes! The system will keep track of changes in order to comply with data collection standards. Additionally, most of the surveys need to be answered on an annual basis or more, in order to track changes to participants’ experience over time. The Program platform or team may send reminders to update surveys and other information. Is it really FREE? Is there any cost associated with participation? The SDS-GPS Program platform (application) is FREE to use for participants, as the cost is covered by the SDS Alliance (sponsor). However, the application utilizes the participant’s cell phone, tablet, or computer, and will utilize their data/internet connection. The application will send notifications and reminders. There may be fees for text messages and data usage as per your plan with your cell phone or internet provider. To facilitate participation by underserved communities, the SDS Alliance may occasionally offer financial assistance to overcome such barriers. Do you provide any incentive for participation? Participants will not be paid for their data. Occasionally, we may offer participants a gift card or other small compensation for their time and effort involved in participation, such as completing certain surveys. If compensation is available, we will tell them the details prior to the start of the activity. The use of data may result in commercial profit, such as a product, material, or process. Participants will not share in any commercial value or profit derived from the use of their data nor will they have special access to any products or therapies created. Will survey results be shared back with me? Yes. We will share results in many different ways. • You can always access your own surveys and answers, and print or share as you wish. • Participants will also be able to see how their survey answers compare to other participants for certain questions, once sufficient participants have filled out the surveys. This is a built-in feature of the Program platform. • To promote the use of the SDS-GPS Program and data, aggregate, de-identified data will be collated at least annually and made available to the public through various means, such as the SDA Alliance or Progam website, newsletter, email or mail, conferences, webinars, social media, or publications. Such information may include data in aggregate of a group of participants, instead of patient-level data, such as the number of participants, the prevalence of individual common diagnoses, demographic information, and level of engagement. How can the SDS-GPS platform help me manage my health information? How can the SDS-GPS platform help me manage my health information? Use it as a personal health monitoring tool Utilize tools and features that make managing daily care easier Share health information easily with others Symptoms and Activities Tracker Track symptoms and activities on the platform, including energy levels, pain, illnesses, medication or diet changes, doctor or therapy appointments, and more! Use an existing favorites list or create your own symptoms and activities list to track those that are meaningful and important to you Graphs can be created with multiple activities and symptoms to look for patterns and possible correlations Medications Tracker Log medications, dosages, and refill dates Text and email notifications for medication administration and refill reminders Important Document Storage and Organization Upload your documents for easy organization and access - medical records, IEP’s, evaluations, medication lists, physician contact lists, guardianship, etc. Documents can be shared as PDF files with healthcare providers, other caregivers, and anyone you'd like to have them Journal Keep notes and written narratives of important information such as changes in eating or sleep, unusual behaviors, parent-teacher interactions, or any other things you want to remember Keep a list of questions for the next doctor's appointment Resource Center Find important documents, forms, and information from the SDS Alliance and other peer-reviewed guidelines and resources to help with your Program participation or make day-to-day life and care easier Find announcements and details about clinical trial opportunities Sharing Center Download and share any information you've entered into Matrix (your own personal health data) with anyone you'd like, such as your healthcare providers, school nurses, care providers, etc... Message Center Two-way communication with the SDS Alliance related to the SDS-GPS Program A safe, secure, and private way to share information and questions

  • Donate | Shwachman-Diamond Syndrome Alliance

    Our work would not be possible without your financial support. We make it simple to make a gift through our online donation tools and more. Your Donation Saves Lives Donate Securely with Credit Card, ACH, or PayPal Give One Time or Monthly Join our Monthly Giving Allies : your monthly contribution will support our work year-round — ensuring that we can maintain our ongoing efforts to make SDS research possible and efficient. To set up a regular donation, select the “Monthly” option on the form on this page, or the Monthly Giving Allies campaign page . You can cancel or make changes anytime. Click here to open the donation form in a new window in case the embedded form is not working for you. donate Double Your Impact Employer Matching Many corporations match employee donations to nonprofit organizations — meaning your gift to SDS Alliance could be doubled, or even tripled, at no extra cost to you. It takes about five minutes. Search for your company using the tool below, and follow your employer's instructions to submit a match request. SDS Alliance is a registered 501(c)(3) nonprofit, and we will provide any documentation your employer needs. Charity Navigator employer matching search lets you Search for your company → Not sure if your company participates? Ask your HR department or check your employee benefits portal. Many people are surprised to find their employer offers this benefit. Questions? Email us at gifts@sdsalliance.org — we are happy to help. Employer-gift-match Monthly Giving Allies is our new community-powered monthly giving circle. It brings together families, caregivers, friends, and supporters who want to help accelerate research, strengthen advocacy, and advance therapy development for Shwachman-Diamond Syndrome. Monthly giving isn’t about the amount. It’s about being counted. When many families give even a small amount each month, it shows researchers, funders, and biotech partners that the SDS community is large, united, and determined to push for progress. Every Ally strengthens our collective voice. Every gift fuels the mission to #CureSDS. Every action takes us closer to Clinical Trials by 2030. Every contribution enables us to give SDS patients more birthdays to celebrate. Why Monthly Giving Matters * Helps fund long-term, high-impact research projects * Demonstrates community strength to funders and scientific partners * Supports therapy development initiatives * Provides predictable, reliable funding * Shows unity and determination within the SDS community Small monthly gifts add up — because there is Strength in Numbers to #CureSDS. Go to Monthly Giving Allies Form Learn More Fundraise with an Event & Personalized Webpage Set up a personalized fundraising page on our GiveLively donation platform , by clicking the "Start a Fundraiser" button on any of our fundraising pages or here . All donations go into the SDS Alliance bank account, and donors receive an automatic receipt right away. You can create fundraisers for any special occasion or to increase your impact at any time of the year. Email gifts@sdsalliance.org for help. We will be happy to assist. Fundraising Tips Download Guide Donate or Fundraise through Facebook We are an approved charity on Facebook. Visit our Facebook page at www.facebook.com/SDSAlliance and use the "Donate" button at the top, donate to an existing fundraiser benefiting us, or create your own personalized fundraiser. Send a Check in the Mail If possible, please give us a heads about your check and confirming the address by emailing us at gifts@sdsalliance.org., so we can keep an eye on it and ensure that you receive a receipt and heartfelt thank you in a timely manner. Make checks payable to Shwachman-Diamond Syndrome Alliance. Send to: Shwachman-Diamond Syndrome Alliance PO Box 2441, Woburn, MA 01888, USA. Wire from Your Bank Please contact us at gifts@sdsalliance.org for details. Use Your Donor Advised Funds New! Our donation form at the top of this page, managed by GiveLively, now offers DAF as an option during checkout. On all our campaign pages. It uses DAFpay by Chariot to securely connect to your Donor-Advised Fund (DAF). After selecting that option, you’ll be asked to log in to your DAF provider. Learn about DAF grants through Give Lively. Open GiveLively Donation Form Alternatively, we also partnered with Every.org to process DAF donations. If you use a Donor Advised Fund (DAF), your receipt from Every.org will not be tax-deductible as the tax deduction was already received at the time you contributed to your DAF. For any other payment method, you will get a tax-deductible receipt emailed to you. Your donation is made to Every.org, a tax-exempt US 501(c)(3) charity that grants unrestricted funds to Shwachman-Diamond Syndrome Alliance Inc on your behalf. As a legal matter, Every.org must provide any donations to Shwachman-Diamond Syndrome Alliance Inc on an unrestricted basis, regardless of any designations or restrictions made by you. FAQ How does Every.org accept my donation? Your donation is made to Every.org, a US 501(c)(3) public charity. Every.org will immediately send you a receipt by email. On a weekly basis, Every.org grants to Shwachman-Diamond Syndrome Alliance Inc. This process ensures your eligibility for a tax deduction, enables you to consolidate your gift records, and reduces the burden on Shwachman-Diamond Syndrome Alliance Inc. Are there any fees? We do not charge any fees to accept DAF gifts, and currently cover all the Chariot fees. Every.org does not charge any platform fee of our own, because we are a nonprofit. Instead, we rely on the generosity of donors to fund our mission of philanthropy for everyone. Will I receive a tax-deductible receipt for my donation? If you use a Donor Advised Fund (DAF), your receipt from Every.org will not be tax-deductible as the tax deduction was already received at the time you contributed to your DAF. For any other payment method, you will get a tax-deductible receipt emailed to you. Open Every.org DAF Donation Form crypto Donate Crypto (NEW) We partnered with Every.org to process Crypto donations. Your donation is made to Every.org, a US 501(c)(3) public charity. Every.org will immediately send you a receipt by email. We then partner with PayPal Grants to grant to Shwachman-Diamond Syndrome Alliance Inc on a monthly basis (or semiannually for balance under $100). This process ensures your eligibility for a tax deduction, enables you to consolidate your gift records, and reduces the burden on Shwachman-Diamond Syndrome Alliance Inc. Are there any fees? Our exchanges generally charge a 1% flat fee to automatically liquidate cryptocurrency. Every.org does not charge any fees of our own. Open Crypto Donation Form Planned Legacy Gifts & Bequests You can leave a legacy while at the same time supporting the mission of the SDS Alliance. We are committed to making your gift meaningful to you. A bequest through your will allows you to designate a specific dollar amount or a percentage of your estate to SDS Alliance. A bequest may reduce the amount of your taxable estate, which may increase the actual amount available to loved ones. Please talk to your attorney or financial advisor to determine the best way to include us in your estate plans. Contact us at connect@sdsalliance.org or +1-617-329-1838. Stock and IRA Charitable Giving Gifts of Stock that have been held for more than 12 months offer two-fold tax savings: a tax deduction for the full fair market value of the stock on the date of the gift and capital gains can be avoided. Please talk to your tax or financial advisor. Individual Retirement Account (IRA) owners over age 70½ may make a transfer of up to $100,000 per year to qualified charities, including Shwachman-Diamond Syndrome Alliance. IRA charitable rollovers are tax-free and not included in adjusted gross income. An IRA charitable rollover may fulfill part or all of your required minimum distribution (RMD). For more information on making an IRA contribution please talk to your tax or financial advisor. Personalized Memorial Page Every life should be celebrated and every loved one should be remembered. Creating a personalized memorial page in loving memory of a loved one is a way to remember those who have recently passed and a way to provide a dedicated link for friends and family to make a donation. You can personalize this page with text and a photo. As long as the page remains active, you can continue to use it to invite gifts in memory of your loved one. To create a personalized memorial page, use our donation platform and click "I want to fundraise for this" as described above. Or, contact us at connect@sdsalliance.org or call us +1-617-329-1838 for assistance. For any questions or comments, please email us at gifts@sdsalliance.org

View All

Blog Posts (142)

  • Global SDS Action Week: Easy Actions You Can Take This Week or Anytime

    Welcome to SDS Spotlight — our monthly series where Eszter shares a quick update on what we're working on, what we're excited about, and how YOU can get involved. Each month features a short video and a deeper dive right here on the blog. In this month's SDS Spotlight, Eszter Hars, Ph.D., molecular biologist, SDS Alliance CEO, and mother of a child with SDS, shares what Global SDS Action Week is about and how to take part, this week or any time. In this month's SDS Spotlight, Eszter Hars, Ph.D., introduces Global SDS Action Week and Awareness Day and invites you to take some easy actions to help move improved treatments and new therapies forward. What is Global SDS Action Week? Global SDS Action Week runs November 1 to 7 and culminates in SDS Awareness Day on November 7. This year, we created an interactive checklist for you, with one simple action a day you can do anytime, anywhere. Check off what you do. Skip what doesn't fit your life right now. Every action is optional, you can do them in any order, and you can do them anywhere in the world. Full details about the week are on our Action Week page. Why November 7? Shwachman-Diamond Syndrome got its name from a paper published in November 1964 by Drs. Shwachman and Diamond, who were practicing at Boston Children's Hospital at that time. In 2003, the gene responsible for most SDS cases was discovered and published by Dr. Rommens at Sick Kids in Canada. The gene was named SBDS, and is located on Chromosome 7 (section 11), also known as 7q11, which reads as 11.7. So the date November 11 represents the name day or birthday of SDS, and represents the whole SDS community, whatever your gene or diagnosis. The seven actions We compiled a list of seven easy actions you can take, one for each day of SDS Action Week. All serve a purpose of coming together as a community and support research and therapy develpment. Join us! Day 1 (November 1): Read the Voice of the Patient report. A year ago, our community shared what life with SDS is really like. Those words became a report that researchers, drug developers, and regulators can now read, in your own words. Read the report. Day 2 (November 2): Make SDS visible in the medical record. In the US, SDS has its own ICD-10 code, D61.02. Share it with your medical team and ask them to confirm it is in the chart. A specific code helps make SDS visible in medical records and research. Read more. Outside the US, SDS Alliance is working on the groundwork for codes in other countries and regions. If you have a medical or coding background and would like to help, email connect@sdsalliance.org. Day 3 (November 3): Add your voice to the research. Join SDS-GPS, our global survey platform, or complete the gene therapy perspectives survey. What you share helps shape research and how clinical trials are designed. Your privacy is protected. Join SDS-GPS, log in, or read about privacy. Day 4 (November 4): Start the SDS PACER Course. It is free and self-paced, with six modules that help you understand the science and take part in research discussions. It also helps prepare you to serve on research and drug development advisory boards. Start the course. Day 5 (November 5): Explore our free guides. School success, the school letter tool, and the interactive gene therapy guide are all in one place. Share one with a teacher, a doctor, or a newly diagnosed family. See all guides. Day 6 (November 6): Give. A monthly gift of any amount helps us give SDS patients and families more birthdays to celebrate, and it shows strength in numbers. Join Monthly Giving Allies. Prefer a one-time gift? Donate here. Day 7 (November 7): Share your story. Post about your life with SDS, or share one fact about it, wherever you are. To contribute more privately, find your chapter in the Essential Guide story tool. Pseudonyms are welcome. Find your chapter. US families: the checklist also has one optional bonus action. Meet Joyce Joyce is a young advocate with SDS who asked her New Jersey assemblywoman to recognize November 7 as Shwachman-Diamond Syndrome Awareness Day. Assembly Joint Resolution 119 passed the Assembly 77 to 0 and the Senate 40 to 0, and Gov. Mikie Sherrill signed it on August 6. Watch our full conversation with Joyce, and read how she did it: Interview with Joyce Joyce's story Why we are doing this Awareness is only the start. What makes a difference is what actions we take. Each of these actions connects to research, better care, or a stronger community: more voices in SDS-GPS, more families who understand the science, and more support for the work ahead. The checklist is ready anytime, so every action works whenever you are ready. Which action will you take first? Tell us on our social posts, or email us at connect@sdsalliance.org. Subscribe to our blog to get email reminders about new posts! ① Login or create an account at the top of this website ② Select Settings in the member’s menu ③ Click on Subscribe Now, and make sure blog posts are selected in the list below

  • How a Young SDS Advocate Got November 7 Recognized as SDS Awareness Day in New Jersey

    On August 6, 2026, Gov. Mikie Sherrill signed Assembly Joint Resolution 119, recognizing November 7 as Shwachman-Diamond Syndrome Awareness Day in New Jersey. The resolution passed the Assembly 77 to 0 and the Senate 40 to 0. Behind this milestone achievement is Joyce, a young advocate with SDS who started speaking up and sharing her SDS story when she was just 13. She brought this idea to her assemblywoman while she was still a teenager, and then saw it through every step. Today she is taking a gap semester, interning in Washington, DC, and starting at NYU in the spring to study public policy. Eszter Hars, PhD, SDS Alliance CEO, sat down with Joyce on October 30, 2026, to ask how she did it, why it matters, and what she would tell other families. Here is what we learned. Watch the full conversation Interview with Joyce about her efforts in getting SDS Awareness Day recognized in New Jersey, and her WHY. About 30 minutes. Recorded October 30, 2026. Why she made it happen Joyce had watched friends in other rare disease communities work to get awareness days for their conditions. She saw a way to do the same for SDS. That's, like, 100 new lawmakers who have never heard of the condition, who are now aware that the condition is a real thing and that real people are impacted by it. SDS affects an estimated 2,000 to 3,000 people in the US, and many doctors have never heard of it. Joyce's goal was simple: let people know the condition exists. We can't get treatment or research or funds if nobody knows that the condition exists. Why November 7 Joyce researched the history of SDS and found that the condition was first described in November 1964 in a publication by Boston Childrens' Hospital doctors Dr. Shwachman and Dr. Diamond, so she chose November. For the day, she picked the 7th, because the SBDS gene (the gene responsible for most SDS cases) is on Chromosome 7, section11 (also known as 7q11). She flipped that into 11/7 or November 7th. I wanted everyone to be able to celebrate their condition even if they weren't genetically diagnosed. That is why the date works for the whole SDS community, whatever their gene or diagnosis. The timeline for the NJ recognition of SDS Awareness Day to be established June 2025: Joyce met with Assemblywoman Linda Carter and shared the idea. The assemblywoman liked it and suggested waiting for the next legislative session to begin. January 2026: The resolution was introduced as AJR 119, with bipartisan support. May 12: Assembly committee hearing. May 18: The Assembly passed it, 77 to 0. June 11: Senate committee hearing. June 30: The Senate passed it, 40 to 0. August 6: Gov. Mikie Sherrill signed it. The resolution asks the governor to issue a proclamation each year recognizing November 7 as Shwachman-Diamond Syndrome Awareness Day. How she did it, step by step Joyce is the first to say that none of this was complicated, just slow. We still give her tremendous credit. A field trip to the State House in her AP Government class in high school showed her how a bill is introduced and sparked the idea. Here is her process: Start with your local representative. Joyce shared the idea with Assemblywoman Carter. They wrote the language together, so that every fact was correct. Introduce the resolution, then campaign for it. She called every office in the State House and asked them to cosponsor. Get leadership on board. Senate President Nick Scutari and Speaker Craig Coughlin cosponsored it. Joyce explains that leaders decide what gets scheduled, so their support helped move the resolution through hearings and votes. Share your story at the hearings. She wrote a speech and testified at both committee hearings, and she was at the State House for the votes. Repeat in the second chamber, then the governor. Be patient. She waited from June to January so that the resolution could be introduced at the start of a session, with enough time to pass both chambers. Rules and calendars differ from state to state. If you want to try this where you live, start with a conversation with your state representative. Her advice to other young people Joyce started advocating at 13 and was scared at first. I have mentored advocates as young as 6 years old, and it doesn't matter what age you are, you can get out there. You could share your story. You could contact your representative. After you do it once or even twice, … you realize how friendly these people are, how they really truly want to listen to their community. What she is pursuing next After the New Jersey resolution, Joyce shared the language with her US representative, and a federal resolution, H.Res.1133, was introduced in the House on March 24, 2026, with Reps. Tom Kean Jr. and Josh Gottheimer as sponsors. At Camp Sunshine, 46 community members signed a letter supporting it. As of November 7, 2026, it is awaiting committee review. Because a new Congress starts in January 2027, the resolution may need to be reintroduced in the next session. Joyce plans to keep going. US families who would like to help can ask their representative to cosponsor H.Res.1133. You will find a short message you can adapt in our Action Week checklist, and the full text of the resolution is on congress.gov. Joyce's advocacy for the federal resolution is her own initiative. SDS Alliance is proud to share her story and to celebrate the New Jersey recognition. More about Joyce Joyce also loves horseback riding, singing, and musical theater, and she performs in New York. She wrote and recorded a song about her SDS experience, titled "Don't Surrender to Fear", as part of the 2026 Rare Artist program from Rare Advocates. More about the song here. She is now working with a producer on a collection of new songs about the rare disease journey, with a full album planned for late 2027. Thank you Thank you, Joyce, for showing what one person with a good idea can do. Thank you to Assemblywoman Linda Carter, Senate President Nick Scutari, Speaker Craig Coughlin, and Gov. Mikie Sherrill for making November 7 official in New Jersey. Share your story, too Joyce's advice applies to all of us: your story matters, and you can share it at any age. There are many ways and opportunities to share your story and make an impact toward more research and clinical trials by 2030, so that SDS patients and families can have more birthdays to celebrate. You can share your story on our blog, on your own social media channels, in your personal network, school, or work. We are here to help with resources and guidance. If you would like to stay more private, consider contributing to our Essential Guide, and find your chapter in our story tool. Pseudonyms are welcome. How to participate in SDS Action Week and Awareness Day Check out our SDS Action Week and Awareness Day page and open the Action Week checklist for more ways to take part. Subscribe to our blog to get email reminders about new posts! ① Login or create an account at the top of this website ② Select Settings in the member’s menu ③ Click on Subscribe Now, and make sure blog posts are selected in the list below

  • The SDS PACER Course Is Now Live! Deep Dive into SDS, Research, and How You Can Make a Difference

    Welcome to SDS Spotlight — our monthly series where Eszter shares a quick update on what we're working on, what we're excited about, and how YOU can get involved. Each month features a short video and a deeper dive right here on the blog. In this month's SDS Spotlight, Eszter Hars, Ph.D. introduces the new SDS PACER Course and highlights additonal opportunities to accelerate research and therapy development. If you live with Shwachman-Diamond Syndrome (SDS) or care for someone who does, you already know more about life with SDS than you think. You know what it feels like to wait for a bone marrow result. You know the exhaustion of explaining SDS to yet another doctor who has never seen it before. You know which questions keep you up at night, and which ones still don't have good answers. Researchers need to hear your insights. It is not just a "nice to have." It is a critical requirement for research and therapy development that actually helps people and families like you and me. This true partnership works best when we speak the same language — when we agree on the basic concepts and feel comfortable discussing them frankly. That is why we built the SDS PACER Course. What Is the SDS PACER Course? The SDS PACER Course — Patient and Family Edition is a free, self-paced online learning series built specifically for the Shwachman-Diamond Syndrome community. Its six modules are designed to help you understand the science behind SDS well enough to participate meaningfully in discussions, research, research prioritization and design, advocacy, and the decisions around your own or your family's care. It is available now at www.sdsalliance.org/courses . Create a free account on the SDS Alliance website and log in at the top of the page, then go to My Programs. Start whenever you are ready, at your own pace, on any device. What You Will Learn The six modules build on each other, from the foundations of patient-centered research to the frontier of SDS therapy development: Module 1 — What Is Patient-Centered Research and Why Does It Matter for SDS? What patient-centered comparative effectiveness research is, how it differs from other kinds of research, and what your role in it can look like — anchored by a presentation from our collaborator Dr. Vanessa Merker of Massachusetts General Hospital and Harvard Medical School. Module 2 — Genes, Proteins, and the SBDS Gene The genetics of SDS in plain language — what genes do, what variants are, how SBDS mutations cause SDS, and what that means for diagnosis, inheritance, and research. Module 3 — Ribosomes, SBDS, and How SDS Affects the Body Why SDS affects so many different organ systems, what ribosomal stress means, and why every patient's experience is different. Module 4 — Clonal Hematopoiesis, Leukemia Risk, and the Future of Treatment What happens in the bone marrow over time in SDS, how researchers are learning to predict leukemia risk, and what that means for surveillance decisions and emerging therapies. Module 5 — Clinical Research and Therapy Development: How Treatments Reach Patients The full arc of drug development — from pre-clinical research through clinical trials and regulatory approval — and the many ways patients and organizations can shape that process. Module 6 — Stem Cell Transplant and Gene Therapy: What's Available Now and Where We Are Headed (coming next week) What HSCT is, how donor matching works, how bone marrow surveillance tools work, and the three gene therapy approaches being developed specifically for SDS — including why gene editing is a better fit than traditional gene therapy. Each module includes videos, written content, and a short quiz. You earn a badge and a certificate for each one you complete. What Will I Get Out of the Course? After completing the course, you will be equipped to make a real difference in many settings: At the doctor: Speak up more clearly and confidently for yourself or your child With researchers: Help scientists design better SDS studies with your informed perspective In the community: Help and teach other SDS families — especially the newly diagnosed In clinical trials: Make decisions about participation with real confidence On advisory boards: Provide an informed patient perspective on research planning With SDS Alliance: Participate in projects and help shape what we build next You do not need a science background. This course is written for people who have been living with SDS — not for researchers*. If you have been managing this condition, or supporting someone who has, you already have the experience. The course gives you the framework to use it. *A course dedicated to clinicians and researchers is coming soon. Built for the Community, With the Community This course was developed through Project PACER — SDS Alliance's two-year initiative funded by the Patient-Centered Outcomes Research Institute (PCORI) to build capacity for patient-centered research in Shwachman-Diamond Syndrome. Our community survey shaped the content by asking what topics matter most to you. Our co-developers — patients and caregivers who test-drove the course and provided thoughtful feedback — helped us clarify and improve the content and . They include adult patients, caregivers of children at every stage of the SDS journey, spanning three continents. When you take the course, you benefit from their work — and have the opportunity to help improve it further. Our goal is clinical trials by 2030. An informed, research-ready community is a critical piece of the puzzle. The course is how we build that together. Frequently Asked Questions Is the course free? Yes. The SDS PACER Course is completely free for all SDS community members worldwide. Do I need a science background? No. The course is written for patients and families, not scientists. Plain language throughout. How long does it take? Each module takes approximately 30–60 minutes. You can take breaks and continue anytime — the course saves your progress automatically. Who can take the course? Anyone in the SDS community — patients, caregivers, parents, partners, and family members. An edition for clinicians and researchers is coming soon. Is it available in other languages? The course is currently available in English. We are exploring additional languages as funding allows. What do I get when I finish? A badge and certificate for each completed module, and a full course certificate when all six are done. Take the SDS PACER Course Free, self-paced, open to the SDS community worldwide. Start the course at www.sdsalliance.org/courses → Create a free account or log in, go to My Programs, and begin with Module 1. Each module takes 30–60 minutes. You can take breaks and continue anytime. Questions or comments? Email us at pacer@sdsalliance.org. All October Resources at a Glance 🎓 Take the new SDS PACER course: www.sdsalliance.org/courses 🧬 New to SDS-GPS? Join here: www.sdsalliance.org/sds-gps-join 🧬 Existing SDS-GPS users, log in and complete your surveys at www.sdsalliance.org/sds-gps-login 🔬 St. Jude GeneTX study + SDS Alliance gene therapy survey: full details at https://www.sdsalliance.org/post/sds-gene-therapy-perspectives-survey 📅 SDS Action Week: November 1–7, 2026. 📞 SDS Family Network Welcome Call: Check the SDS Alliance Family Network (Facebook group) or email connect@sdsalliance.org Questions? Contact us anytime at connect@sdsalliance.org Project PACER is funded by the Patient-Centered Outcomes Research Institute (PCORI), Engagement Award EASO-42419. Subscribe to our blog to get email reminders about new posts! ① Login or create an account at the top of this website ② Select Settings in the member’s menu ③ Click on Subscribe Now, and make sure blog posts are selected in the list below

View All
bottom of page